Plexin A3 (PLXNA3) is a member of the plexin family of transmembrane receptors that mediate semaphorin signaling in the nervous system. It plays critical roles in axonal guidance, synaptic plasticity, and neural circuit formation during development and in the adult brain 1.
Plexin A3 possesses a characteristic domain architecture consisting of:
- Extracellular Domain: Contains multiple semaphorin-binding domains (SBDs) and cysteine-rich repeats (CRs) that mediate ligand recognition and receptor clustering
- Transmembrane Region: Single pass membrane-spanning helix that anchors the receptor in the plasma membrane
- Cytoplasmic Domain: Contains a Ras GTPase-activating protein (GAP) domain that regulates downstream signaling through small GTPases including R-Ras, M-Ras, and Rap1 2
The extracellular domains form complexes with neuropilins (NRP1/NRP2) as co-receptors, which enhance semaphorin binding affinity and specificity.
Plexin A3 mediates repulsive axonal guidance in response to semaphorin cues:
- Class 3 Semaphorins: Sema3A, Sema3B, Sema3C, Sema3F signals through Plexin A3 to cause growth cone collapse and axonal repulsion
- Corticospinal Tract: Guides corticospinal motor axons during development
- Olfactory System: Regulates olfactory bulb interneuron migration and circuit formation
Beyond development, Plexin A3 continues to function in the mature nervous system:
- Regulates dendritic spine morphology and synaptic stability
- Modulates excitatory synaptic transmission through NMDA receptor trafficking
- Participates in experience-dependent plasticity in the hippocampus
Plexin A3 contributes to the formation of specific neural circuits:
- Hippocampal circuit patterning
- Cortical interneuron migration
- Thalamocortical axon guidance
Plexin A3 has been implicated in Alzheimer's disease pathogenesis through several mechanisms 3:
- Neuronal Connectivity: Altered semaphorin signaling affects dendritic arborization and synaptic connectivity in cortical and hippocampal neurons
- Amyloid Response: Sema3A signaling through Plexin A3 can modulate amyloid-beta induced neurotoxicity
- Tau Pathology: Semaphorin-Plexin signaling intersects with tau phosphorylation pathways
- Therapeutic Potential: Modulating Plexin A3 signaling may restore neuronal connectivity in early AD
In ALS, Plexin A3 plays complex roles:
- Motor Neuron Axons: Regulates axonal maintenance and regeneration capacity
- Ventral Root Exit: Guides motor axon exit from the spinal cord
- Disease Modification: Genetic variants may modify disease progression
Mutations in PLXNA3 have been associated with:
- Autism spectrum disorders through effects on synaptic development
- Intellectual disability due to altered cortical connectivity
The semaphorin-plexin pathway represents a therapeutic target for neurodegeneration:
- Semaphorin Antagonists: Small molecule inhibitors blocking Sema3A-Plexin A3 signaling to promote neuronal regeneration
- Plexin A3 Agonists: Enhancing pathway activity to restore synaptic function
- Neuroprotective Strategies: Targeting downstream effectors including PI3K/Akt and MAPK/ERK pathways
Plexin A3 activates multiple downstream signaling cascades:
- Rho GTPase Signaling: GAP domain inactivates R-Ras, leading to integrin deactivation and growth cone collapse
- PI3K/Akt Pathway: Regulates cell survival and axonal extension
- MAPK/ERK Pathway: Controls gene expression and synaptic plasticity
- Focal Adhesion Kinase (FAK): Modulates cytoskeletal dynamics through integrin signaling
Plexin A3 interacts with multiple proteins:
- Neuropilins: NRP1 and NRP2 as co-receptors for semaphorin binding
- Plexin A Subfamily: Can form heteromeric complexes with Plexin A2 and A4
- Rho GTPases: R-Ras, M-Ras, Rap1 as GAP substrates
- Adapter Proteins: Crk, p130Cas for downstream signaling
- MICAL Family: Monooxygenases that regulate actin cytoskeleton
Current research focuses on:
- Understanding cell-type specific functions in different neuronal populations
- Developing brain-penetrant small molecules targeting Plexin A3
- Exploring gene therapy approaches for neurological disorders
- Investigating the intersection with other neurodegenerative disease pathways
- Semaphorin signaling in neural development and disease (2023)
- Plexin receptors in neurodegeneration (2022)
- Plexin A3 and amyloid-beta interplay in Alzheimer's disease (2023)
- Class 3 semaphorins in the central nervous system (2021)
- Axonal guidance molecules in ALS (2022)